Darren Bryan retweeted
Aren’t You the Valet? Tales of Black American Surgeons | NEJM Today, in the US, it is as if there are 2 different scripts being loudly declaimed trying to drown each other out. The escalating chant “BLM” is countered by … cancel culture & White supremacy. nejm.org/doi/full/10.10…
17
174
503
140,406
5 year follow up from a 2018 phase-II pilot study of neoadj. nivolumab (nejm.org/doi/full/10.10…). Impressive outcomes!

aacr.org/about-the-aacr…
And here is a graphic of the five year outcomes!
0
0
3
632
Darren Bryan retweeted
Thank you for sharing your experience!

Hearing my patients’ stories over the years during surveillance has led me to believe (even though i cannot prove) that PFTs have value in risk-stratification, but they do not predict patient experience.
@FarhoodFarjah YES! My PFT's were fine post lobectomy but I was easily SOB when playing sports w/my 4 kids. AND there's only a finite amount of lung - I lived that horror/reality w/my aunt, whose 3rd stage I killed her because she didn’t have enough lung capacity to survive another surgery!
0
1
3
1,084
Darren Bryan retweeted
Delighted to announce MARS 2 data is now mature and we aim to report this year! Thank you to our patients, UK investigators, @BrsTrialsCentre, @NIHRresearch @CRUKresearch for 7 years of hard work!!
2
18
84
12,307
💯
Well said. Couldn’t agree more.
#tssmn #MedEd #SurgEd
@SethBKrantz @DSBryan1 @ElliotServaisMD @DavidCookeMD @TomVargheseJr @DrShawnGroth @BrendonStilesMD @ShandaBlackmon @LindaMThoracic Agree with a disease-based rather than procedure-based approach to knowledge acquisition for the subspecialist surgeon practicing non-cardiac thoracic surgery.
0
0
1
571
Here here! Congratulations @JBMatthews! So well deserved.
CONGRATULATIONS, Dr. Matthews! From all of us, we are lucky to call your our Chair! 🎉

@JBMatthews @UnivSurg @AcademicSurgery #ASC2023
0
0
2
532
Darren Bryan retweeted
AUDARA update with longer F/U but OS data still withheld ascopubs.org/doi/pdf/10.120…

Interesting👀 Brain mets incidence starts to rise AFTER 3 years osi is up in stage II/IIIA while in control group it plateaus at ~10%. So does osi really only delay recurrence?🧐

Do we need MRIs???
5
26
86
47,249
Darren Bryan retweeted
Replying to @sorin_mark
Importantly, for clinical relevance, we show that we can predict recurrence after surgery in a cohort of Stage 1A-B lung cancer patients by using machine learning and as a result can inform on adjuvant treatment strategies. We don’t need 35 markers- we can do this with just 6! 🙌🏼
1
3
16
2,235
Darren Bryan retweeted
Dr John Alverdy’s last day in the OR after 30 years at @uchicagosurgery Thousands of patients have benefited from his expertise, and his legacy includes hundreds of trainees - THE BEST. #ThankYou @UChicagoMed #EndOfAnEra #TheLegend #NewChapter #HesNotGoingAnywhere
48
93
1,238
352,245
Darren Bryan retweeted
Replying to @lungoncdoc
@esinghimd @ADesaiMD @FDAOncology @DrSteveMartin @n8pennell @JackWestMD Here’s some help: just do neoadj and you’ll hardly ever have to think about this adj business. The real question is whether there’s value in adj IO for patients who received neoadj chemo-IO. That’s the real question for which we will soon have some useful data. #LCSM
4
1
11
594
Darren Bryan retweeted
I am incredibly appreciative to be at an institution that values diversity and equity. I am proud of the work we do to combat structural racism and improve access to care. @UChicagosurgery promotes a positive and inclusive environment
Learn about our extraordinary Chief of Thoracic Surgery Dr Jessica Donington and who she is “behind the mask”. @jdoningtonmd @uchicagosurgery

surgeryar.bsd.uchicago.edu/sections/thora…
1
5
45
5,936
Darren Bryan retweeted
Issue Information ‐ TOC onlinelibrary.wiley.com/doi/10.1002/js…

This month's issue of JSO puts the spotlight on thoracic oncology and our own Dr. Mike Jacklitsch @BrighamSurgery @BrighamThoracic
1
3
7
1,144
Darren Bryan retweeted
Dr Altorki presenting his ‘labor of love’ CALGB 140503. For peripheral T1a, surgical outcomes, disease free and overall survival not statistically different looking at lobar vs sublobar. Important to note recurrence is 30% for both groups! More data coming at the AATS! #STS2023
1
12
32
4,590
Darren Bryan retweeted
Awesome presentation highlighting important work by @JackKentMD @LuciaMadariaga looking at the cost-effectiveness of ex-vivo lung perfusion for patients undergoing lung transplantation #STS2023 @uchicagosurgery @uchicagosurgres @UChicagoCTSurg
0
5
19
2,146
And always beware the diaspora of responsibility!
0
0
1
409
Darren Bryan retweeted
Awesome lecture, incredible visit. Impossible not to be inspired!!
Starting the new year off strong with Dr. Zara Cooper here for the inaugural Jill Hitchcock Memorial Annual Trauma lecture!

Thrilled to have her here from @BrighamSurgery to learn about her extensive work with older surgical patients in trauma and beyond.
0
2
5
1,079
Nice paper in @annalsthorsurg this morning:
Impressive differential risk of LN mets in patients with solid vs. mixed GGO less than 2cm who are clin. node neg. Check out those odds ratios!

#lcsm #tssmn @tssmn
annalsthoracicsurgery.org/article/S0003-…
1
9
16
3,224
Extremely proud of our trauma surgery colleagues @uchicagosurgery. Phenomenal surgeons and humans—THIS is what taking care of the whole patient looks like. Not just the physical injuries.
At The University of Chicago Medicine, we are pioneering innovative programs to address the legal aids of our trauma victims to lead to holistic recovery after violent trauma. @uchicagosurgery @UChicagoMed
0
1
13
Darren Bryan retweeted
Replying to @ElliotServaisMD
@Clavikul @CtiaGaspar8 @AndresFCardonaZ @LaheyHospital @DouglasEWood1 @NCCN Because as @DouglasEWood1 has point out…

With current USPSTF guidelines, if you enter lung cancer screening and quit smoking at age 50, then the only way to qualify for screening beyond age 65 (a peak age group for lung cancer) would be to start smoking again!! 🤯🤯🤦🏼‍♂️🤦🏼‍♂️
1
2
3